Is ADHD Genetic? What the Heritability Data Actually Shows

ADHD is one of the most heritable conditions in psychiatry. Twin studies consistently put the heritability of ADHD at around 70 to 80 percent, similar to height and considerably higher than most other psychiatric conditions ^{[1, 3]}. This article explains what that figure means, what genome-wide studies have actually found, and why environment still matters.

The headline number: heritability of 70 to 80 percent

A heritability estimate of 0.7 to 0.8 means that, in the populations studied, roughly 70 to 80 percent of the variation in whether someone meets criteria for ADHD is accounted for by genetic variation, with the rest accounted for by environmental factors and measurement error ^{[1, 3]}.

That figure has held up across decades of twin studies in multiple countries ^[3]. Identical twins show much higher concordance for ADHD than fraternal twins, and first-degree relatives of someone with ADHD have a meaningfully elevated risk compared to the general population ^[1].

Two things worth flagging up front:

• Heritability is a population statistic, not an individual one. It tells you what proportion of population-level variance is genetic; it does not tell you that 70 percent of any one person's ADHD "is genetic" and 30 percent "is environment".
• Heritability is not the same as inevitability. High heritability means genes have a strong influence; it does not mean environment has none.

ADHD is polygenic, not monogenic

There is no "ADHD gene". The genetic architecture of ADHD is polygenic: many genes contribute small individual effects, and combinations and interactions produce the overall risk ^{[2, 3]}.

The first genome-wide significant risk loci for ADHD were identified in 2019 by Demontis and colleagues in a study of over 55,000 people ^[2]. Twelve independent loci reached genome-wide significance, and the polygenic risk score derived from the study showed a small but reliable association with ADHD diagnosis. Since then the number of identified loci has grown.

Importantly, the genetic architecture of ADHD overlaps substantially with other conditions, including autism, depression, anxiety, schizophrenia and educational attainment ^{[2, 3]}. This is partly why ADHD has so many co-occurring conditions: the underlying genetic risk is shared.

What this means for families

If one biological parent has ADHD, the probability that a child also has ADHD is meaningfully higher than the population baseline, though estimates vary by study ^{[1, 3]}. If both parents have ADHD, the risk is higher again. If a sibling has ADHD, the risk to other siblings is elevated.

In practice, the most common pattern seen in clinic is a child being assessed and the parent recognising themselves in the diagnostic interview. This is a real and well-documented phenomenon. Many adult assessments at NeuroFX begin with "my child has just been diagnosed and I think I have it too".

This is also why a careful family history is part of any private adult ADHD assessment or ADHD assessment for children. NICE NG87 explicitly recommends gathering this as part of the diagnostic interview ^[5].

Environment still matters

High heritability does not mean environment is irrelevant. It means environmental factors account for a smaller share of the variance in who develops ADHD, not that they do nothing. The international consensus statement identifies several environmental factors with reasonable evidence of association ^[1]:

• Prematurity and very low birth weight
• Prenatal exposure to alcohol or nicotine
• Severe early-life adversity, including neglect or institutional care
• Lead exposure in childhood (a small effect)

These do not cause ADHD on their own. They interact with genetic vulnerability. A child with high polygenic risk and significant early adversity is at higher risk than a child with either factor alone.

A few environmental claims that are often repeated but not supported by the evidence:

• Sugar does not cause ADHD ^[1].
• Food additives have a small, real effect on hyperactivity in some children but do not cause ADHD ^[1].
• Screen time and "phones" do not cause ADHD. ADHD has been clinically described for over a century. The genetic data is clear and predates smartphones by a long way ^[1].
• Parenting style does not cause ADHD. Parenting affects how ADHD plays out, particularly emotional regulation and self-esteem, but does not create the underlying neurobiology ^[1].

What about epigenetics?

Epigenetic mechanisms (changes in how genes are expressed without changing the DNA sequence) are a live area of research in ADHD. Early work has found some associations, but the evidence is still preliminary and far from clinically actionable ^[3]. It is worth knowing that the field is open and likely to refine the picture over the next decade, while the headline finding (high heritability, polygenic architecture, overlap with other conditions) is unlikely to change.

What this means in practice

• If ADHD runs in your family, that is clinically relevant information. Bring it to any assessment.
• If you have been diagnosed and you have biological children, watch for early signs but do not assume. Heritability is a probability, not a guarantee.
• Do not let the genetic framing become fatalistic. ADHD is highly treatable. Environment, support, education, structure and (where appropriate) medication all change the trajectory.
• If your child is diagnosed and you recognise yourself in the assessment, ask the clinician about adult assessment for yourself. It is one of the most common entry routes to adult ADHD diagnosis in the UK.

When to speak to a professional

Speak to your GP if the pattern is persistent, runs in the family, and affects daily life. Your GP can refer to the NHS, to an NHS-contracted provider under Right to Choose in England, or you can self-refer privately. NeuroFX offers CQC-registered ADHD assessment for adults and for children aged 6 and upwards from our Bedford clinic. Seek same-day help via 111 (or 999 in an emergency) for any mental health crisis.

Sources

1. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
2. Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics. 2019;51:63-75.
3. Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry. 2019;24(4):562-575.
4. Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240-1250.
5. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87